Sweet advance for treatment of children with multi-drug resistant TB

Children with multi-drug resistant tuberculosis (MDR-TB) undergo months of life-saving treatment including many doses of foul-tasting medications, which caregivers often struggle to prepare and administer accurately. New findings from the Global Alliance for TB Drug Development (TB Alliance) and Stellenbosch University, in South Africa now provide detailed blueprints for pharmacists to quickly and safely prepare more palatable, more accurately dosed syrup suspensions for key drugs against MDR- TB. The researchers hope their work will significantly improve treatment outcomes of children with MDR-TB. Read more here.